Logo image of PODD

INSULET CORP (PODD) Stock Price, Quote, News and Overview

NASDAQ:PODD - Nasdaq - US45784P1012 - Common Stock - Currency: USD

287.77  +2.86 (+1%)

After market: 287.77 0 (0%)

PODD Quote, Performance and Key Statistics

INSULET CORP

NASDAQ:PODD (8/4/2025, 8:00:00 PM)

After market: 287.77 0 (0%)

287.77

+2.86 (+1%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High329.33
52 Week Low180.31
Market Cap20.25B
Shares70.36M
Float70.08M
Yearly DividendN/A
Dividend YieldN/A
PE79.71
Fwd PE52.63
Earnings (Next)08-07 2025-08-07/bmo
IPO05-15 2007-05-15


PODD short term performance overview.The bars show the price performance of PODD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 2 -2 -4 -6

PODD long term performance overview.The bars show the price performance of PODD in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30 40 50

The current stock price of PODD is 287.77 USD. In the past month the price decreased by -4.3%. In the past year, price increased by 57.95%.

INSULET CORP / PODD Daily stock chart

PODD Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 26.52 226.06B
ISRG INTUITIVE SURGICAL INC 60.04 173.27B
BSX BOSTON SCIENTIFIC CORP 37.73 157.99B
SYK STRYKER CORP 29.69 145.79B
MDT MEDTRONIC PLC 16.3 114.85B
IDXX IDEXX LABORATORIES INC 59.89 54.91B
BDX BECTON DICKINSON AND CO 12.7 51.27B
EW EDWARDS LIFESCIENCES CORP 31.16 46.98B
RMD RESMED INC 30.52 42.73B
GEHC GE HEALTHCARE TECHNOLOGY 15.16 32.34B
DXCM DEXCOM INC 44.85 29.90B
PHG KONINKLIJKE PHILIPS NVR- NY 16.29 25.73B

About PODD

Company Profile

PODD logo image Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts and currently employs 3,900 full-time employees. The company went IPO on 2007-05-15. The company is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. The company also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. Omnipod 5 includes an AID algorithm embedded in the Pod.

Company Info

INSULET CORP

100 Nagog Park

Acton MASSACHUSETTS 01720 US

CEO: Shacey Petrovic

Employees: 3900

PODD Company Website

PODD Investor Relations

Phone: 19786007000

INSULET CORP / PODD FAQ

What is the stock price of INSULET CORP today?

The current stock price of PODD is 287.77 USD. The price increased by 1% in the last trading session.


What is the ticker symbol for INSULET CORP stock?

The exchange symbol of INSULET CORP is PODD and it is listed on the Nasdaq exchange.


On which exchange is PODD stock listed?

PODD stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for INSULET CORP stock?

32 analysts have analysed PODD and the average price target is 345.71 USD. This implies a price increase of 20.13% is expected in the next year compared to the current price of 287.77. Check the INSULET CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is INSULET CORP worth?

INSULET CORP (PODD) has a market capitalization of 20.25B USD. This makes PODD a Large Cap stock.


How many employees does INSULET CORP have?

INSULET CORP (PODD) currently has 3900 employees.


What are the support and resistance levels for INSULET CORP (PODD) stock?

INSULET CORP (PODD) has a support level at 280.95 and a resistance level at 287.8. Check the full technical report for a detailed analysis of PODD support and resistance levels.


Is INSULET CORP (PODD) expected to grow?

The Revenue of INSULET CORP (PODD) is expected to grow by 23.03% in the next year. Check the estimates tab for more information on the PODD EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy INSULET CORP (PODD) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does INSULET CORP (PODD) stock pay dividends?

PODD does not pay a dividend.


When does INSULET CORP (PODD) report earnings?

INSULET CORP (PODD) will report earnings on 2025-08-07, before the market open.


What is the Price/Earnings (PE) ratio of INSULET CORP (PODD)?

The PE ratio for INSULET CORP (PODD) is 79.71. This is based on the reported non-GAAP earnings per share of 3.61 and the current share price of 287.77 USD. Check the full fundamental report for a full analysis of the valuation metrics for PODD.


What is the Short Interest ratio of INSULET CORP (PODD) stock?

The outstanding short interest for INSULET CORP (PODD) is 3.03% of its float. Check the ownership tab for more information on the PODD short interest.


PODD Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to PODD. When comparing the yearly performance of all stocks, PODD is one of the better performing stocks in the market, outperforming 84.13% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

PODD Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to PODD. While PODD has a great profitability rating, there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PODD Financial Highlights

Over the last trailing twelve months PODD reported a non-GAAP Earnings per Share(EPS) of 3.61. The EPS increased by 12.11% compared to the year before.


Industry RankSector Rank
PM (TTM) 18.29%
ROA 11.43%
ROE 30.22%
Debt/Equity 1.21
Chartmill High Growth Momentum
EPS Q2Q%38.36%
Sales Q2Q%28.82%
EPS 1Y (TTM)12.11%
Revenue 1Y (TTM)23.49%

PODD Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 84% to PODD. The Buy consensus is the average rating of analysts ratings from 32 analysts.

For the next year, analysts expect an EPS growth of 32.73% and a revenue growth 23.03% for PODD


Ownership
Inst Owners102.51%
Ins Owners0.28%
Short Float %3.03%
Short Ratio2.91
Analysts
Analysts84.38
Price Target345.71 (20.13%)
EPS Next Y32.73%
Revenue Next Year23.03%